Advertisement
Advertisement
HELP
Helus Pharma Inc. Common Stock
8.96
USDSponsored
+0.57
+6.79%
Nov 06, 15:59 UTC -5
Closed
After-Market
9.02
+0.05
+0.61%
Helus Pharma Inc. Common Stock (HELP) Earnings
HELP Earnings Reports
Positive Surprise Ratio
HELP beat 0 of 4 last estimates.
0%
Next Report
In 2 Days
Date of Next Report
Nov 11, 2026
Estimate for Q2 27 (Revenue/ EPS)
--
/-$0.81
Implied change from Q1 27 (Revenue/ EPS)
--
/-10.99%
Implied change from Q2 26 (Revenue/ EPS)
--
/-50.00%
Helus Pharma Inc. Common Stock earnings per share and revenue
On Aug 14, 2026, HELP reported earnings of -0.91 USD per share (EPS) for Q1 27, missing the estimate of -0.71 USD, resulting in a -26.99% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.72% price change (close before vs. close after earnings).
Looking ahead to Q2 27, 4 analysts forecast an EPS of -0.81 USD, with revenue projected to reach -- USD, implying an decrease of -10.99% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Cronos Group Inc. Common Share
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.03
Actual
$0.04
Surprise
+17.65%
Aclaris Therapeutics, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.16
Actual
-$0.12
Surprise
+28.49%
Protara Therapeutics, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.35
Surprise
+6.17%
Minerva Neurosciences, Inc
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.12
Actual
$1.94
Surprise
+1,629.97%
Organogenesis Holdings Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.17
Actual
-$0.25
Surprise
-40.06%
ZOETIS INC.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.52
Actual
$1.75
Surprise
+14.64%
Dyne Therapeutics, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.92
Actual
-$1.06
Surprise
-15.57%
Amylyx Pharmaceuticals, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.38
Actual
-$0.38
Surprise
+1.04%
Aldeyra Therapeutics, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.06
Surprise
+37.43%
Lipocine Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.36
Actual
-$0.08
Surprise
+77.91%
FAQ
What were Helus Pharma Inc. Common Stock's earnings and revenue for the latest quarter Q1 2027?
For Q1 2027, Helus Pharma Inc. Common Stock reported EPS of -$0.91, missing estimates by -26.99%, and revenue of $0.00, 0% as expectations.
How did the market react to Helus Pharma Inc. Common Stock's Q1 2027 earnings?
The stock price moved up 4.72%, changed from $11.45 before the earnings release to $11.99 the day after.
When is Helus Pharma Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 11, 2026.
What are the forecasts for Helus Pharma Inc. Common Stock's next earnings report?
Based on 4
analysts, Helus Pharma Inc. Common Stock is expected to report EPS of -$0.81 and revenue of -- for Q2 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.